CARCINOEMBRYONIC ANTIGEN (CEA) MARKET NextGen Technological Advancements, Professional Survey & Industry Trends - 2025

The Carcinoembryonic Antigen (CEA) Market was worth USD 1.36 billion in the year of 2012 and is expected to reach approximately USD 2.51 billion by 2022, while registering itself at a compound annual growth rate (CAGR) of 5.64% during the forecast period. The Global carcinoembryonic antigen market is anticipated to encounter significant development over the estimate time on account of factors like increasing predominance of cancer and the advancement of novel biomarkers. Evaluations distributed by the World Health Organization, recommend that in 2012, the overall cancer occurrences were almost 14.1 Million, which included 7.4 million male and 6.7 million female patients. The world Age-Standardized (AS) rate reflects that there are about 205 new cases of cancer for each 100,000 men globally, and 165 for each 100,000 women.

Fill the form for an exclusive sample of this report @: http://www.crystalmarketresearch.com/report-sample/HC10279

Moreover, the existence of ideal government activities relating to the awareness of cancer and control by associations, for example, the National Cancer Institute, and the Cancer Prevention and Control Research Network (CPCRN) is relied upon to emphatically fortify market development. Advancement of novel biomarkers which can be utilized as a part of mix with different biomarkers is probably going to play a significant part in driving business sector development over the gauge time frame. Quickly expanding aged populace base inclined to endless therapeutic conditions including cancer is probably going to extend the purchaser base. Technological enhancements in proteomics including mass spectrometry, protein bioinformatics, imaging, array based methodologies, and labeling of protein have enabled scientists to quickly find more biomarkers and to better comprehend their parts. Furthermore, presentation and steady advancement of novel immunological procedures, for example, the radioimmunoassay is anticipated to elevate the requirement for carcinoembryonic antigen tests over the figure time frame.

Application Outlook and Trend Analysis

Major applications sections of the carcinoembryonic antigen market comprise thyroid cancer, pancreatic cancer, breast cancer, colorectal cancer and ovarian cancer among others. In 2014, the market was dominated by carcinoembryonic antigen for colorectal cancer on the basis of revenue. Major factors that contribute to its vast share are growing demand for minimally obtrusive diagnostic methods, increasing aged population, rising predominance of unhealthy ways of life like irregular eating patterns. Moreover, the consumption of alcohol and inactive lifestyle may be the reason behind the growth of colorectal cancer in the upcoming years. Breast cancer is anticipated to be the rapidly developing segment and is foreseen to encounter substantial growth in the following years.

Market Classification

Carcinoembryonic Antigen (CEA) Market, By Application, Estimates and Forecast, 2012-2022 ($Million)

CEA Based Pancreatic Cancer
CEA Based Ovarian Cancer
CEA Based Thyroid Cancer
CEA Based Colorectal Cancer
CEA Based Breast Cancer
Other Applications

Carcinoembryonic Antigen (CEA) Market, By Region, Estimates and Forecast, 2012-2022 ($Million)

North America
North America Carcinoembryonic Antigen (CEA) Market, By Country
North America Carcinoembryonic Antigen (CEA) Market, By Application
U.S. Carcinoembryonic Antigen (CEA) Market, By Application
Canada Carcinoembryonic Antigen (CEA) Market, By Application
Mexico Carcinoembryonic Antigen (CEA) Market, By Application

Browse Market Research Report @: http://www.crystalmarketresearch.com/report/carcinoembryonic-antigen-cea-market

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

About Crystal Market Research
Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contact:
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
Email: sales@crystalmarketresearch.com
Website: http://www.crystalmarketresearch.com

This release was published on openPR.